Skip to main content
. 2013 Aug 19;6:99–108. doi: 10.2147/JIR.S48422

Figure 2.

Figure 2

Cardiac fibroblast proliferation (A), cardiac fibroblast hydroxyproline (HPro) release (B), and matrix metalloproteinase-2 (MMP-2) activity (C) in medium in response to coculture of cardiac fibroblasts with untreated inflammatory cells (IC) and cardiac inflammatory cells in conjunction with a neutralizing antibody against TNF-α (IC + anti-TNF-α). *P < 0.05 versus control; #P < 0.05 versus IC.

Abbreviations: BrdU, 5-bromo-2′-deoxyuridine; TNF-α, tumor necrosis factor-alpha.